FARALLON CAPITAL MANAGEMENT LLC
Q1 2026 13F Holdings
- Locationsan francisco, CA
- Num holdings
172
- Value ($000)
$17,542,714
- Date Filed 05/15/2026
- Form type13F-HR
- CIK 0000909661
- All SEC filings
- NoteHoldings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q1 2026 toSelect Quarter
Issuer Name | Class | CUSIP | VALUE | % | Shares | Principal | Option Type |
|---|---|---|---|---|---|---|---|
STATE STR SPDR S&P 500 ETF T | TR UNIT | 78462F953 | $1.5B | 9 % | 2,300,000 | put | |
REVOLUTION MEDICINES INC | COM | 76155X100 | $1.32B | 8 % | 13,604,796 | ||
AMAZON COM INC | COM | 023135106 | $878.56M | 5 % | 4,218,394 | ||
MICROSOFT CORP | COM | 594918104 | $867.97M | 5 % | 2,344,779 | ||
AON PLC | SHS CL A | G0403H108 | $811.03M | 5 % | 2,512,638 | ||
BRIDGEBIO PHARMA INC | COM | 10806X102 | $695.48M | 4 % | 9,365,463 | ||
INVESCO EXCHANGE TRADED FD T | S&P500 EQL WGT | 46137V957 | $690.91M | 4 % | 3,600,000 | put | |
PROTAGONIST THERAPEUTICS INC | COM | 74366E102 | $669.17M | 4 % | 6,348,906 | ||
NATERA INC | COM | 632307104 | $641.44M | 4 % | 3,207,366 | ||
EXELIXIS INC | COM | 30161Q104 | $562.33M | 3 % | 13,111,010 |
Rows Per Page
10
- 10
- 50
- 100